Cardio Renal Summit - 2025

The Cardio Renal Summit – 2025 is a virtual, two‑day continuing professional development (CPD) forum that brings together distinguished cardiology, nephrology, and endocrinology specialists from across the globe. Through live faculty commentaries, real‑world patient cases, and audience‑driven polling, the programme traverses the entire cardiorenal continuum—from early risk recognition to evidence‑based intervention—emphasizing the emerging role of SGLT2 inhibitors and the power of multidisciplinary collaboration. Expect an immersive learning experience designed to sharpen clinical judgment, update guideline familiarity, and translate data into tangible patient benefits.

WHY YOU SHOULD ATTEND

1. Fresh, guideline‑aligned content. Gain first‑hand insight into 2024–2025 updates from ESC, KDIGO, ADA, and ACC concerning cardiorenal risk reduction and the positioning of dapagliflozin.

2. Case‑based mastery. Work through anonymised T2D, CKD, and HF cases, compare your decisions with international peers, and receive faculty feedback in real time.

3. Practical implementation tools. Leave with step‑by‑step algorithms, dosing checklists, and monitoring templates for integrating dapagliflozin into routine care.

4. Multidisciplinary lens. Hear how cardiologists, nephrologists, diabetologists, and pharmacists co‑manage complex patients for optimal outcomes.

5. Accredited CPD points. Secure recognized credits (via Ghana’s Medical and Dental Council) without leaving your workspace.

6. Global networking. Engage with a high‑calibre faculty and colleagues from multiple regions, expanding your professional contacts and perspectives.

EVENT HIGHLIGHTS (SNAPSHOT)

i. Interactive clinical cases: Live polling on diagnostic and therapeutic inflection points in T2D, CKD, and HF.

ii. Anonymised insight reports: Instant group‑level analytics drive discussion of decision patterns and evidence gaps.

iii. Guideline‑update masterclasses: Concise reviews of ESC/KDIGO/ADA guidance and implications for frontline practice.

iv. Dapagliflozin in focus: Efficacy across etiologies, initiation strategies (HFrEF, HFpEF, CKD, T2D), and side‑effect mitigation.

v. Debunking misconceptions: Tackling the “diabetes drug” label and reaffirming the cardiorenal benefits of SGLT2 inhibition.

vi. Multidisciplinary panel forum: Practical tips for coordinated care, early referral, and shared therapeutic accountability.

SUMMARY OF TOPICS TO BE PRESENTED

1. Global Burden of Cardiorenal Disease & the Call to Action

2. Evidence for Dapagliflozin in T2D Patients with Cardiorenal Risk

3. Dapagliflozin for HFrEF & HFpEF: Initiation and Clinical Positioning

4. Dapagliflozin in CKD: Efficacy Across Etiologies, Dosing, and Safety

5. Real‑World CKD Case Workshop & Data‑Driven Q&A

6. Real‑World HF Case Workshop & Data‑Driven Q&A

7. Practical Algorithms for GDMT Implementation & Comorbidity Management

8. Overcoming Therapeutic Inertia: From Perception to Practice

9. Multidisciplinary Team Strategies for Optimised Cardiorenal Care

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for the Cardio Renal Summit – 2025, you consent to participate in this training hosted by Continuous Education Services (CES) on behalf of AstraZeneca. Your registration provides us with the information required to facilitate the event and to issue CPD accreditation through the Medical and Dental Council (MDC). CES is committed to safeguarding your personal information and will not share any personal data with AstraZeneca. Data will be transmitted solely to relevant regulatory bodies (e.g., MDC) for the purpose of allocating CPD points earned through this training. You may opt out of the meeting at any time without further action, and your participation will be treated with the highest degree of confidentiality.

SPONSORED BY

This will be a virtual event. It will be streamed LIVE on this page.

Date: Fri, the 25th July 2025

Time: 14:00 - 1600 GMT (2:00- 4:00 pm Local Time) 

Target Audience: General Practitioners (GPs)

The agenda is available to download in the downloads section.